1-20 of 26
Keywords: Endometrial carcinoma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Gynecol Obstet Invest (2020) 85 (1): 34–40.
Published Online: 05 September 2019
...Xiao-fei Sun; Shu-yan Dai Objectives: To explore the expression of Galectin-1 and -9 and clinicopathological features in endometrial carcinoma (EC). Methods: Normal endometrium (NE), atypical endometrial hyperplasia (AH), and endometrial cancer were collected, and immunohistochemistry was used...
Journal Articles
Gynecol Obstet Invest (2019) 84 (3): 283–289.
Published Online: 12 December 2018
...Aharon Feldman; Sadaf Chaugle; Charlotte Burmeister; Adnan Munkarah; Mohamed A. Elshaikh Objective: To compare survival endpoints between African American (AA) and non-AA (NAA) women with endometrial carcinoma (EC) stage I–II using a robust matching analysis. Methods and Materials: Patients were...
Journal Articles
Journal Articles
Gynecol Obstet Invest (2017) 82 (1): 30–38.
Published Online: 18 March 2016
...Huizhen Sun; Li Yan; Ruiqin Tu; Yuqin Zhang; Li Ma; Wenbin Tang; Long Li; Wei Chen; Cheng Zhan; Rongyu Zang Background: This study was to explore the expression profile of endometrial carcinoma (EC) and identify the potential molecular mechanism and therapeutic targets. Methods: Differentially...
Journal Articles
Gynecol Obstet Invest (2015) 79 (2): 126–135.
Published Online: 27 January 2015
...Pedro Acién; Irene Velasco; Maribel Acién; Cecilia Capello; Pilar Vela Aims: To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma. Methods: An observational cohort study performed in 192...
Journal Articles
Journal Articles
Gynecol Obstet Invest (2013) 75 (1): 68–72.
Published Online: 14 December 2012
... endometrial carcinoma tissues to understand the relationship between its expression and clinicopathological characteristics. Methods: ER-α36 expression was assessed by immunostaining in 73 endometrial carcinomas, 20 normal endometrial tissues, and 9 with atypical endometrial hyperplasia. Correlations between...
Journal Articles
Journal Articles
Gynecol Obstet Invest (1982) 13 (4): 213–225.
Published Online: 16 March 2010
...C.Y. Genton; K.A. Büchi The histological and ultrastructural features of 15 endometrial carcinomas were analyzed and recorded without knowledge of the steroid receptor content which was determined in the cytosol of the tumor tissue. Serum levels of estrogens were determined in all patients...
Journal Articles
Gynecol Obstet Invest (1987) 24 (2): 138–144.
Published Online: 15 March 2010
...Pierluigi Benedetti Panici; Pier Franco Di Roberto; Pasquale Alessandro Margariti; Giovanni Scambia; Adriano Bompiani; Salvatore Mancuso The authors have re-examined 146 patients with stage I and II endometrial carcinoma according to pathological findings. An understaging of FIGO classification...
Journal Articles
Gynecol Obstet Invest (1984) 18 (4): 190–193.
Published Online: 15 March 2010
...David Levran; Michaela Modan; Joseph Menczer; Mordechai Dulitzy Glycosylated hemoglobin was compared in 22 unselected endometrial carcinoma cases 1–10 years (mean ± SD = 3.3 + 2.8) after diagnosis and in 939 controls, a representative population sample in the same age range tested for oral glucose...
Journal Articles
Gynecol Obstet Invest (1987) 24 (4): 262–270.
Published Online: 15 March 2010
...Zoltá;n Szarvas; Bé;la Zsolnai; Gá;bor Gimes; Judit Hidvégi The morphological effect of a high-dose progestogen (Depo-Provera) on highly differentiated endometrial carcinoma was studied. Thirteen patients were treated by progestogen only, given at the beginning ofthe treatment in a weekly dose...
Journal Articles
Gynecol Obstet Invest (1984) 18 (1): 16–20.
Published Online: 15 March 2010
...N. Crona; L. Enk; L.G. Friberg; G. Samsioe; G. Silfverstolpe 21 women (mean age 60 years, range 48–72) were given depot medroxyprogesterone acetate (DMPA), 1,000 mg/week parenterally for 6 months, as part of the treatment for endometrial carcinoma in either clinical stage I or II. Before treatment...
Journal Articles
Journal Articles
Gynecol Obstet Invest (1994) 38 (4): 276–280.
Published Online: 01 March 2010
...Chyong-Huey Lai; Chin-Yi Wang; Chieh-Yu Lin; Chia C. Pao The presence of human papillomavirus (HPV) type 16 and 18 transcripts was determined by reverse transcription/polymerase chain reaction (PCR) in ovarian and endometrial carcinoma tissue. HPV-16 DNA sequences were detected in 50.0% (9/18...
Journal Articles
Gynecol Obstet Invest (1994) 37 (4): 275–278.
Published Online: 01 March 2010
...Ryou Misao; Atsushi Imai; Keisuke Wada; Teruhiko Tamaya Estrone (E 1 ), a principal estrogen in postmenopausal women, may have profound consequences in the maintenance and progression of hormone-sensitive endometrial carcinoma. This study was designed to investigate the specific binding sites for E...
Journal Articles
Journal Articles
Gynecol Obstet Invest (2009) 67 (1): 57–60.
Published Online: 09 October 2008
... and UPSC tumors. 17 12 2007 3 06 2008 9 10 2008 Sulfatase Endometrium Endometrial carcinoma Dehydroepiandrosterone sulfate © 2008 S. Karger AG, Basel 2008 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...
Journal Articles
Gynecol Obstet Invest (2006) 61 (4): 200–202.
Published Online: 17 May 2006
...Peter Uharček; Miloš Mlynček; Jozef Ravinger Background: Gynecologic cancers metastatic to bone are rare. Endometrial carcinoma usually presents with vaginal bleeding. Case Report: A 67-year-old woman presented with pain, erythema and swelling of the right foot and no history of postmenopausal...